Overview
Shigetaka Shimodaira practices in Kahoku, Japan. Shimodaira is rated as a Distinguished expert by MediFind in the treatment of Wilms Tumor. Their top areas of expertise are Wilms Tumor, WT1-Related Wilms Tumor Syndromes, Hemolytic Transfusion Reaction, and Renal Cell Carcinoma (RCC).
Their clinical research consists of co-authoring 57 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 20 articles in the study of Wilms Tumor.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Wilms TumorShimodaira isDistinguished. Learn about Wilms Tumor.
- Advanced
- Hemolytic Transfusion ReactionShimodaira isAdvanced. Learn about Hemolytic Transfusion Reaction.
- WT1-Related Wilms Tumor SyndromesShimodaira isAdvanced. Learn about WT1-Related Wilms Tumor Syndromes.
- Experienced
- Cytomegalovirus InfectionShimodaira isExperienced. Learn about Cytomegalovirus Infection.
- Lung AdenocarcinomaShimodaira isExperienced. Learn about Lung Adenocarcinoma.
- Pancreatic CancerShimodaira isExperienced. Learn about Pancreatic Cancer.
- Renal Cell Carcinoma (RCC)Shimodaira isExperienced. Learn about Renal Cell Carcinoma (RCC).